International Journal of Molecular Medical Science, 2024, Vol.14, No.1, 16-23 http://medscipublisher.com/index.php/ijmms 20 extensive clinical trial data, medical literature, and actual clinical data, artificial intelligence conducts knowledge discovery and pattern recognition. This provides physicians with guidance on the effectiveness and side effects of different treatment approaches, assisting in the optimization of treatment plans. Artificial intelligence can also utilize patients' genomic data to predict their responses to different drugs, offering personalized drug selection and dosages. By continuously monitoring patients' health data in real-time and providing personalized treatment recommendations, artificial intelligence can assist patients and healthcare professionals in promptly adjusting treatment plans in a timely manner for more precise personalized therapy (Boniolo et al., 2021). The application of artificial intelligence in molecular medicine research provides new perspectives and methods for treatment response and personalized therapy, fostering the implementation of personalized medicine in the healthcare field and providing better medical outcomes for patients. 3 Opportunities of Artificial Intelligence in Molecular Medicine 3.1 Enhance research efficiency and accuracy Artificial intelligence presents significant opportunities in molecular medicine research aimed at improving research efficiency and accuracy. Through data analysis and mining, AI can efficiently process large-scale molecular biology data, spanning from genomics to proteomics and metabolomics data, thereby accelerating the research process. AI plays a crucial role in drug screening and virtual screening, utilizing machine learning algorithms to rapidly assess the activity and properties of candidate compounds, providing accurate references for drug research. Additionally, the application of artificial intelligence enables the prediction and simulation of protein structures and functions, facilitating the design and development of novel drugs. Through pattern recognition and disease classification, AI contributes to improving the accuracy of early disease diagnosis and treatment selection, realizing personalized therapy. Real-time monitoring and prediction constitute another critical area where AI technology can continuously monitor patients' physiological parameters and health data, establishing predictive models to forecast disease progression and treatment outcomes for timely adjustments to treatment plans. The application of artificial intelligence in molecular medicine research provides extensive opportunities to improve research efficiency and accuracy, promising substantial advancements in medical research. 3.2 Accelerating drug research and development Artificial intelligence presents numerous opportunities in molecular medicine, one of which is to accelerate the process of the drug research and development (Huang et al., 2021). Through efficient data mining and machine learning algorithms, AI can rapidly screen and evaluate the activity and properties of a large number of candidate compounds, thereby improving the speed and success rate of drug development. Additionally, AI can predict and simulate the interaction between drugs and targets, guiding drug design and optimization to discover more active and selective drug molecules. Moreover, data-driven drug repositioning methods can apply existing drugs to new indications, saving time and costs. Personalized drug therapy represents another significant opportunity, where artificial intelligence utilizes patients' genomic data and clinical information to provide personalized treatment recommendations for physicians, aiming to enhance efficacy and reduce side effects. Furthermore, AI can predict drug interactions and side effects, assisting physicians in assessing the safety and selectivity of medications. In summary, artificial intelligence has accelerated the process of drug development and transformation in molecular medicine, providing robust support for the smooth development of new drugs and personalized treatment. 3.3 Advancing precision medicine Artificial intelligence offers numerous opportunities in advancing precision medicine within molecular medicine. Genomics stands out as a crucial domain among them. By analyzing patients' genomic data, artificial intelligence can identify gene variations and mutations associated with diseases, providing support for early detection and personalized treatment. Additionally, AI can predict drug responsiveness, assisting physicians in selecting the most suitable drug treatment plans. Another significant opportunity lies in data analysis. Through the efficient data
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==